Literature DB >> 1752082

The spread of human lung cancer cells on collagens and its inhibition by type III collagen.

K Hirai1, H Shimada, T Ogawa, S Taji.   

Abstract

The cell spreading ability of human lung cancer cells on collagen substrata was examined in comparison with normal human tracheal epithelial cells. Plastic dishes or multiwells were coated with type I, III or IV collagen gel at a concentrate of 200 micrograms/cm2. Ninety per cent of the normal cells were round on all collagens. Adenocarcinoma RERF-LC-MS and VMRC-LCD cell lines and squamous cell carcinoma VMRC-LCP cell line, which metastasize weakly after intrasplenic transplantation in nude mice, spread relatively poorly. Adenocarcinoma, A549 and SK-LU-1 and squamous cell carcinoma Calu-1 cell lines, which were highly metastatic to liver, spread well. Adenocarcinoma ABC-1 cell line, which is moderately metastatic to liver in nude mice, spread moderately. On type III collagen, three adenocarcinoma cell lines (A549, ABC-1 and VMRC-LCD) gradually started to contract after initial spreading and became round at 24 h. These results suggest that there may be a correlation between the degree of malignancy of human lung cancer cells and their spreading ability on collagen substrata, and that the cell spreading ability may be regulated by type III collagen in some lung cancer cells.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1752082     DOI: 10.1007/bf01768580

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  23 in total

1.  Epithelial regeneration in collagen-coated and uncoated patch grafts implanted into dog tracheas.

Authors:  K Hirai; Y Shimizu; T Hino
Journal:  J Exp Pathol (Oxford)       Date:  1990-02

2.  Tumor cell autocrine motility factor.

Authors:  L A Liotta; R Mandler; G Murano; D A Katz; R K Gordon; P K Chiang; E Schiffmann
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

3.  (Alpha1(3))3 human skin collagen. Release by pepsin digestion and preponderance in fetal life.

Authors:  E H Epstein
Journal:  J Biol Chem       Date:  1974-05-25       Impact factor: 5.157

Review 4.  [Collagen--its function and metabolism].

Authors:  R Hata
Journal:  Tanpakushitsu Kakusan Koso       Date:  1986-01

5.  Chemotactic response of rat mammary adenocarcinoma cell clones to tumor-derived cytokines.

Authors:  K D Atnip; L M Carter; G L Nicolson; M K Dabbous
Journal:  Biochem Biophys Res Commun       Date:  1987-08-14       Impact factor: 3.575

6.  Absence of HeLa cell contamination in 169 cell lines derived from human tumors.

Authors:  J Fogh; W C Wright; J D Loveless
Journal:  J Natl Cancer Inst       Date:  1977-02       Impact factor: 13.506

7.  Type II alveolar cells in organotypic culture. A model system for the study of surfactant synthesis.

Authors:  M J Engle; R L Sanders; W H Douglas
Journal:  Biochim Biophys Acta       Date:  1980-02-22

8.  In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors.

Authors:  D J Giard; S A Aaronson; G J Todaro; P Arnstein; J H Kersey; H Dosik; W P Parks
Journal:  J Natl Cancer Inst       Date:  1973-11       Impact factor: 13.506

9.  Cytokine-induced pseudopodial protrusion is coupled to tumour cell migration.

Authors:  R Guirguis; I Margulies; G Taraboletti; E Schiffmann; L Liotta
Journal:  Nature       Date:  1987 Sep 17-23       Impact factor: 49.962

10.  Metastatic potential prediction by a visual grading system of cell motility: prospective validation in the Dunning R-3327 prostatic adenocarcinoma model.

Authors:  J L Mohler; A W Partin; J T Isaacs; D S Coffey
Journal:  Cancer Res       Date:  1988-08-01       Impact factor: 12.701

View more
  9 in total

1.  A modified Boyden chamber assay for tumor cell transendothelial migration in vitro.

Authors:  Y H Li; C Zhu
Journal:  Clin Exp Metastasis       Date:  1999-07       Impact factor: 5.150

Review 2.  Collagen induced MMP-2 activation in human breast cancer.

Authors:  E W Thompson; M Yu; J Bueno; L Jin; S N Maiti; F L Palao-Marco; H Pulyaeva; J W Tamborlane; R Tirgari; I Wapnir
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

3.  Tumor suppressor in lung cancer 1 (TSLC1) alters tumorigenic growth properties and gene expression.

Authors:  Thomas E Sussan; Mathew T Pletcher; Yoshinori Murakami; Roger H Reeves
Journal:  Mol Cancer       Date:  2005-08-05       Impact factor: 27.401

4.  High Energy Particle Radiation-associated Oncogenic Transformation in Normal Mice: Insight into the Connection between Activation of Oncotargets and Oncogene Addiction.

Authors:  Natarajan Aravindan; Sheeja Aravindan; Krishnan Manickam; Mohan Natarajan
Journal:  Sci Rep       Date:  2016-11-23       Impact factor: 4.379

5.  Inhibition of TRPC6 reduces non-small cell lung cancer cell proliferation and invasion.

Authors:  Li-Li Yang; Bing-Chen Liu; Xiao-Yu Lu; Yan Yan; Yu-Jia Zhai; Qing Bao; Paul W Doetsch; Xingming Deng; Tiffany L Thai; Abdel A Alli; Douglas C Eaton; Bao-Zhong Shen; He-Ping Ma
Journal:  Oncotarget       Date:  2017-01-17

Review 6.  Collagens and Cancer associated fibroblasts in the reactive stroma and its relation to Cancer biology.

Authors:  Neel I Nissen; Morten Karsdal; Nicholas Willumsen
Journal:  J Exp Clin Cancer Res       Date:  2019-03-06

7.  Automated sample preparation with SP3 for low-input clinical proteomics.

Authors:  Torsten Müller; Mathias Kalxdorf; Rémi Longuespée; Daniel N Kazdal; Albrecht Stenzinger; Jeroen Krijgsveld
Journal:  Mol Syst Biol       Date:  2020-01       Impact factor: 11.429

8.  Prognostic value of blood-based fibrosis biomarkers in patients with metastatic colorectal cancer receiving chemotherapy and bevacizumab.

Authors:  Neel I Nissen; Stephanie Kehlet; Mogens K Boisen; Maria Liljefors; Christina Jensen; Astrid Z Johansen; Julia S Johansen; Janine T Erler; Morten Karsdal; Joachim H Mortensen; Anette Høye; Nicholas Willumsen
Journal:  Sci Rep       Date:  2021-01-13       Impact factor: 4.379

9.  Delineating the Tes Interaction Site in Zyxin and Studying Cellular Effects of Its Disruption.

Authors:  Ermin Hadzic; Marie Catillon; Aliaksandr Halavatyi; Sandrine Medves; Marleen Van Troys; Michèle Moes; Michelle A Baird; Michael W Davidson; Elisabeth Schaffner-Reckinger; Christophe Ampe; Evelyne Friederich
Journal:  PLoS One       Date:  2015-10-28       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.